共 50 条
Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical Trials
被引:3
|作者:
Sachanas, Sotirios
[1
]
Pangalis, Gerassimos A.
[1
]
Fink, Anna-Maria
[2
,3
]
Bahlo, Jasmin
[2
,3
]
Fischer, Kirsten
[2
,3
]
Levidou, Georgia
[3
,4
,5
]
Kyrtsonis, Marie-Christine
[6
]
Bartzi, Vassiliki
[7
]
Vassilakopoulos, Theodoros P.
[8
]
Kalpadakis, Christina
[9
]
Koulieris, Efstathios
[1
]
Moschogiannis, Maria
[1
]
Yiakoumis, Xanthi
[1
]
Tsirkinidis, Pantelis
[1
]
Angelopoulou, Maria K.
[8
]
Eichhorst, Barbara
[2
,3
]
Hallek, Michael
[2
,3
]
机构:
[1] Athens Med Ctr, Psychikon Branch, Dept Haematol, 1 Andersen Str, Athens 11525, Greece
[2] Univ Hosp Cologne, German CLL Study Grp, Dept Internal Med 1, Cologne, Germany
[3] Univ Hosp Cologne, German CLL Study Grp, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany
[4] Univ Athens, Pathol Dept, Athens, Greece
[5] Humanpathol GmbH, Pathol Dept, Erlangen, Germany
[6] Univ Athens, Laikon Gen Hosp, Dept Propedeut 1, Athens, Greece
[7] Gen Hosp Karditsa, Dept Haematol, Kardhitsa, Greece
[8] Univ Athens, Laikon Gen Hosp, Dept Haematol, Athens, Greece
[9] Univ Crete, Univ Hosp, Dept Haematol, Iraklion, Greece
关键词:
Small lymphocytic lymphoma;
treatment;
proliferation centers;
PROLIFERATION CENTERS;
CYCLOPHOSPHAMIDE;
CLASSIFICATION;
FLUDARABINE;
RITUXIMAB;
D O I:
10.21873/anticanres.13382
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background: Only few studies have focused exclusively on patients with small lymphocytic lymphoma (SLL). Patients and Methods: In the present report, 103 SLL patients were analyzed from both, clinical trials of the German Chronic Lymphocytic Leukemia Study Group and Greek centers, and emphasis was placed on the therapeutic strategy. The impact of lymph node characteristics, such as the presence of proliferation centers (PCs) on response and survival was also assessed. Results: SLL patients included in clinical trials were treated mostly with fludarabine-based regimens while those in "reallife" were staged and treated mostly as patients with low-grade lymphomas. Our analysis showed a trend for better survival for patients with SLL without detectable PCs. Conclusion: Patients with SLL outside of clinical trials are usually treated as cases of lymphoma. In addition, this analysis supports published data regarding the adverse prognostic value of the presence of PCs in lymphoid nodes in SLL.
引用
收藏
页码:2591 / 2598
页数:8
相关论文